New Medical Technology Fundings, September 2014

Fundings in medical technology for the month of September 2014 stand at $421 million, led by the $46 million funding of Vital Therapies. Below are the top fundings for the month thus far.

Company, fundingProduct/technology
Vital Therapies, Inc., has raised $46 million in a public stock offering according to press reportsTechnologies for the regeneration of liver tissue
Fractyl Laboratories, Inc., has raised $40 million in a Series C round of funding according to a regulatory filingEndoscopic device to aid in type 2 diabetes glucose management
Corindus Vascular Robotics, Inc., has raised $26.67 million in a round of funding according to a regulatory filingRobotic system to assist interventional cardiologists with stent placement
Acutus Medical, Inc., has raised $26.2 million in a Series B round of funding, according to press reportsMinimally invasive, 3D cardiac imaging/mapping technology
iHealth Lab has raised $25 million from Xiaomi Ventures, according to press reportsWireless blood-pressure and blood-glucose monitoring
Ivantis, Inc., has raised $25 million adding to its existing Series B round of funding according to press reportsDevice for the treatment of glaucoma
Minerva Surgical, Inc., has raised $25 million in a round of funding according to a regulatory filingAblation device for the treatment of menorrhagia
REVA Medical, Inc., has raised $25 million in new funding according to the companyBioresorbable scaffold for use in vascular stents

For the complete list of medtech fundings in September 2014, see link. For a historical list of the fundings in medtech, by month, since 2009, see link.

Leave a Reply